Literature DB >> 32144488

Glucose transporters in the kidney in health and disease.

Volker Vallon1,2,3.   

Abstract

The kidneys filter large amounts of glucose. To prevent the loss of this valuable fuel, the tubular system of the kidney, particularly the proximal tubule, has been programmed to reabsorb all filtered glucose. The machinery involves the sodium-glucose cotransporters SGLT2 and SGLT1 on the apical membrane and the facilitative glucose transporter GLUT2 on the basolateral membrane. The proximal tubule also generates new glucose, particularly in the post-absorptive phase but also to enhance bicarbonate formation and maintain acid-base balance. The glucose reabsorbed or formed by the proximal tubule is primarily taken up into peritubular capillaries and returned to the systemic circulation or provided as an energy source to further distal tubular segments that take up glucose by basolateral GLUT1. Recent studies provided insights on the coordination of renal glucose reabsorption, formation, and usage. Moreover, a better understanding of renal glucose transport in disease states is emerging. This includes the kidney in diabetes mellitus, when renal glucose retention becomes maladaptive and contributes to hyperglycemia. Furthermore, enhanced glucose reabsorption is coupled to sodium retention through the sodium-glucose cotransporter SGLT2, which induces secondary deleterious effects. As a consequence, SGLT2 inhibitors are new anti-hyperglycemic drugs that can protect the kidneys and heart from failing. Recent studies discovered unique roles for SGLT1 with implications in acute kidney injury and glucose sensing at the macula densa. This review discusses established and emerging concepts of renal glucose transport, and outlines the need for a better understanding of renal glucose handling in health and disease.

Entities:  

Keywords:  Diabetic nephropathy; GLUT1; Gluconeogenesis; Glucose transport; SGLT1; SGLT2 inhibition

Mesh:

Substances:

Year:  2020        PMID: 32144488      PMCID: PMC7483786          DOI: 10.1007/s00424-020-02361-w

Source DB:  PubMed          Journal:  Pflugers Arch        ISSN: 0031-6768            Impact factor:   3.657


  210 in total

Review 1.  Insulin regulation of PEPCK gene expression: a model for rapid and reversible modulation.

Authors:  P G Quinn; D Yeagley
Journal:  Curr Drug Targets Immune Endocr Metabol Disord       Date:  2005-12

2.  Primary proximal tubule hyperreabsorption and impaired tubular transport counterregulation determine glomerular hyperfiltration in diabetes: a modeling analysis.

Authors:  K Melissa Hallow; Yeshitila Gebremichael; Gabriel Helmlinger; Volker Vallon
Journal:  Am J Physiol Renal Physiol       Date:  2017-02-01

3.  Glucose transporters in human renal proximal tubular cells isolated from the urine of patients with non-insulin-dependent diabetes.

Authors:  Hassan Rahmoune; Paul W Thompson; Joanna M Ward; Chari D Smith; Guizhu Hong; John Brown
Journal:  Diabetes       Date:  2005-12       Impact factor: 9.461

4.  Expression cloning and cDNA sequencing of the Na+/glucose co-transporter.

Authors:  M A Hediger; M J Coady; T S Ikeda; E M Wright
Journal:  Nature       Date:  1987 Nov 26-Dec 2       Impact factor: 49.962

5.  Increased NHE3 abundance and transport activity in renal proximal tubule of rats with heart failure.

Authors:  Bruna H Inoue; Leonardo dos Santos; Thaissa D Pessoa; Ednei L Antonio; Bruna P M Pacheco; Fernanda A Savignano; Luciene R Carraro-Lacroix; Paulo J F Tucci; Gerhard Malnic; Adriana C C Girardi
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2011-10-26       Impact factor: 3.619

6.  Regulation of the human Na+-dependent glucose cotransporter hSGLT2.

Authors:  Chiara Ghezzi; Ernest M Wright
Journal:  Am J Physiol Cell Physiol       Date:  2012-06-06       Impact factor: 4.249

Review 7.  Genital and urinary tract infections in diabetes: impact of pharmacologically-induced glucosuria.

Authors:  Suzanne Geerlings; Vivian Fonseca; David Castro-Diaz; James List; Shamik Parikh
Journal:  Diabetes Res Clin Pract       Date:  2014-01-08       Impact factor: 5.602

8.  Fingerprints of hSGLT5 sugar and cation selectivity.

Authors:  Chiara Ghezzi; Edurne Gorraitz; Bruce A Hirayama; Donald D F Loo; Rolf Grempler; Eric Mayoux; Ernest M Wright
Journal:  Am J Physiol Cell Physiol       Date:  2014-02-26       Impact factor: 4.249

9.  Diabetes increases facilitative glucose uptake and GLUT2 expression at the rat proximal tubule brush border membrane.

Authors:  Joanne Marks; Nicolas J C Carvou; Edward S Debnam; Surjit K Srai; Robert J Unwin
Journal:  J Physiol       Date:  2003-09-08       Impact factor: 5.182

10.  Interindividual Heterogeneity of SGLT2 Expression and Function in Human Pancreatic Islets.

Authors:  Chiara Saponaro; Markus Mühlemann; Ana Acosta-Montalvo; Anthony Piron; Valery Gmyr; Nathalie Delalleau; Ericka Moerman; Julien Thévenet; Gianni Pasquetti; Anais Coddeville; Miriam Cnop; Julie Kerr-Conte; Bart Staels; François Pattou; Caroline Bonner
Journal:  Diabetes       Date:  2020-01-02       Impact factor: 9.461

View more
  16 in total

1.  A role for tubular Na+/H+ exchanger NHE3 in the natriuretic effect of the SGLT2 inhibitor empagliflozin.

Authors:  Akira Onishi; Yiling Fu; Rohit Patel; Manjula Darshi; Maria Crespo-Masip; Winnie Huang; Panai Song; Brent Freeman; Young Chul Kim; Manoocher Soleimani; Kumar Sharma; Scott Culver Thomson; Volker Vallon
Journal:  Am J Physiol Renal Physiol       Date:  2020-09-07

2.  Cholesterol Metabolism in Chronic Kidney Disease: Physiology, Pathologic Mechanisms, and Treatment.

Authors:  Xiaoyue Pan
Journal:  Adv Exp Med Biol       Date:  2022       Impact factor: 2.622

Review 3.  The sugar daddy: the role of the renal proximal tubule in glucose homeostasis.

Authors:  Zahraa S Hotait; Julia N Lo Cascio; Elijah N D Choos; Blythe D Shepard
Journal:  Am J Physiol Cell Physiol       Date:  2022-08-01       Impact factor: 5.282

4.  Aristolochic acid-induced nephropathy is attenuated in mice lacking the neutral amino acid transporter B0AT1 (Slc6a19).

Authors:  Aleix Navarro Garrido; Young Chul Kim; Yuji Oe; Haiyan Zhang; Maria Crespo-Masip; Helen A Goodluck; Sadhana Kanoo; Paul W Sanders; Stefan Bröer; Volker Vallon
Journal:  Am J Physiol Renal Physiol       Date:  2022-08-18

Review 5.  Renoprotective Effects of SGLT2 Inhibitors.

Authors:  Volker Vallon
Journal:  Heart Fail Clin       Date:  2022-10       Impact factor: 2.828

6.  Aminoaciduria and metabolic dysregulation during diabetic ketoacidosis: Results from the diabetic kidney alarm (DKA) study.

Authors:  Isabella Melena; Federica Piani; Kalie L Tommerdahl; Cameron Severn; Linh T Chung; Alexis MacDonald; Carissa Vinovskis; David Cherney; Laura Pyle; Carlos A Roncal-Jimenez; Miguel A Lanaspa; Arleta Rewers; Daniël H van Raalte; Gabriel Cara-Fuentes; Chirag R Parikh; Robert G Nelson; Meda E Pavkov; Kristen J Nadeau; Richard J Johnson; Petter Bjornstad
Journal:  J Diabetes Complications       Date:  2022-04-28       Impact factor: 3.219

Review 7.  SGLT2 Inhibitors: Emerging Roles in the Protection Against Cardiovascular and Kidney Disease Among Diabetic Patients.

Authors:  George Vasquez-Rios; Girish N Nadkarni
Journal:  Int J Nephrol Renovasc Dis       Date:  2020-10-28

Review 8.  Effects of SGLT2 Inhibitors on Kidney and Cardiovascular Function.

Authors:  Volker Vallon; Subodh Verma
Journal:  Annu Rev Physiol       Date:  2020-11-16       Impact factor: 19.318

9.  A special issue on glucose transporters in health and disease.

Authors:  Hermann Koepsell; Volker Vallon
Journal:  Pflugers Arch       Date:  2020-08-11       Impact factor: 4.458

Review 10.  Fanconi-Bickel Syndrome: A Review of the Mechanisms That Lead to Dysglycaemia.

Authors:  Sanaa Sharari; Mohamad Abou-Alloul; Khalid Hussain; Faiyaz Ahmad Khan
Journal:  Int J Mol Sci       Date:  2020-08-31       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.